179 related articles for article (PubMed ID: 1751761)
1. HIV-1 gag proteins in virions and in infected cell fractions.
Sharova NK; Grigor'ev VB; Bukrinskaya AG
Biomed Sci; 1991; 2(3):279-84. PubMed ID: 1751761
[TBL] [Abstract][Full Text] [Related]
2. p17 and p17-containing gag precursors of input human immunodeficiency virus are transported into the nuclei of infected cells.
Sharova N; Bukrinskaya A
AIDS Res Hum Retroviruses; 1991 Mar; 7(3):303-6. PubMed ID: 2064827
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of cellular and humoral immune responses to human immunodeficiency virus type 1 Gag and Pol by a G/P-92 fusion protein expressing highly immunogenic Gag p17/p24 and Pol p51 antigens.
Kmieciak D; Bolesta E; Naito T; Gzyl J; Kaneko Y; Kozbor D
J Hum Virol; 2001; 4(6):306-16. PubMed ID: 12082397
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HIV-1 replication in primary human T cells transduced with an intracellular anti-HIV-1 p17 antibody gene.
Tewari D; Notkins AL; Zhou P
J Gene Med; 2003 Mar; 5(3):182-9. PubMed ID: 12666184
[TBL] [Abstract][Full Text] [Related]
5. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
6. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.
Müller B; Daecke J; Fackler OT; Dittmar MT; Zentgraf H; Kräusslich HG
J Virol; 2004 Oct; 78(19):10803-13. PubMed ID: 15367647
[TBL] [Abstract][Full Text] [Related]
7. Immunization of human HIV-seronegative volunteers with recombinant p17/p24:Ty virus-like particles elicits HIV-1 p24-specific cellular and humoral immune responses.
Martin SJ; Vyakarnam A; Cheingsong-Popov R; Callow D; Jones KL; Senior JM; Adams SE; Kingsman AJ; Matear P; Gotch FM
AIDS; 1993 Oct; 7(10):1315-23. PubMed ID: 8267904
[TBL] [Abstract][Full Text] [Related]
8. Antibody recognition of synthetic peptides mimicking immunodominant regions of HIV-1 p24 and p17 proteins.
Lottersberger J; Salvetti JL; Beltramini LM; Tonarelli G
Rev Argent Microbiol; 2004; 36(4):151-7. PubMed ID: 15786866
[TBL] [Abstract][Full Text] [Related]
9. Fine specificity of IgG subclass response to group antigens in HIV-1-infected patients.
Broliden PA; Morfeldt-Månsson L; Rosen J; Jondal M; Wahren B
Clin Exp Immunol; 1989 May; 76(2):216-21. PubMed ID: 2503275
[TBL] [Abstract][Full Text] [Related]
10. Human immunodeficiency virus type 1 infection of endothelial cells in vitro.
Re MC; Furlini G; Cenacchi G; Preda P; La Placa M
Microbiologica; 1991 Apr; 14(2):149-52. PubMed ID: 1713288
[TBL] [Abstract][Full Text] [Related]
11. [Expression and characterization of HIV-1 Gag p17-p24 protein].
Li TY; Jin NY; Wang HW; Guo ZR; Fang HH; An RG; Yin Z
Sheng Wu Gong Cheng Xue Bao; 2000 Jan; 16(1):65-8. PubMed ID: 10883279
[TBL] [Abstract][Full Text] [Related]
12. Use of the presence of anti-protein gag antibodies as an evolution marker of HIV infection.
Neguţ EA; Usein CR; Sfartz S; Zugun-Eloae F
Roum Arch Microbiol Immunol; 1999; 58(2):131-46. PubMed ID: 11845452
[TBL] [Abstract][Full Text] [Related]
13. [HIV-1 p17 matrix protein is transported into the cell nucleus and binds with genomic viral RNA].
Bukrinskaia AG; Vorkunova GK; Tentsov IuIu
Mol Biol (Mosk); 1993; 27(1):49-57. PubMed ID: 8483474
[TBL] [Abstract][Full Text] [Related]
14. Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
Hughes BP; Booth TF; Belyaev AS; McIlroy D; Jowett J; Roy P
Virology; 1993 Mar; 193(1):242-55. PubMed ID: 8438569
[TBL] [Abstract][Full Text] [Related]
15. Proline residues in the HIV-1 NH2-terminal capsid domain: structure determinants for proper core assembly and subsequent steps of early replication.
Fitzon T; Leschonsky B; Bieler K; Paulus C; Schröder J; Wolf H; Wagner R
Virology; 2000 Mar; 268(2):294-307. PubMed ID: 10704338
[TBL] [Abstract][Full Text] [Related]
16. Infectious HIV-1 assembles in late endosomes in primary macrophages.
Pelchen-Matthews A; Kramer B; Marsh M
J Cell Biol; 2003 Aug; 162(3):443-55. PubMed ID: 12885763
[TBL] [Abstract][Full Text] [Related]
17. cDNA encoding a single-chain antibody to HIV p17 with cytoplasmic or nuclear retention signals inhibits HIV-1 replication.
Tewari D; Goldstein SL; Notkins AL; Zhou P
J Immunol; 1998 Sep; 161(5):2642-7. PubMed ID: 9725267
[TBL] [Abstract][Full Text] [Related]
18. Neutralization of human immunodeficiency virus type 1 (HIV-1) with antibody from carriers' plasma against HIV-1 protein p17.
Kageyama S; Katsumoto T; Taniguchi K; Ismail SI; Shimmen T; Sasao F; Gao M; Owatari S; Wakamiya N; Tsuchie H; Ueda S; Shiraki K; Kurimura T
Acta Virol; 1996 Sep; 40(4):195-200. PubMed ID: 9014009
[TBL] [Abstract][Full Text] [Related]
19. HIV-1 infection and virus production in follicular dendritic cells in lymph nodes. A case report, with analysis of isolated follicular dendritic cells.
Parmentier HK; van Wichen D; Sie-Go DM; Goudsmit J; Borleffs JC; Schuurman HJ
Am J Pathol; 1990 Aug; 137(2):247-51. PubMed ID: 2117396
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of HIV-1 replication and infectivity by expression of a fusion protein, VPR-anti-integrase single-chain variable fragment (SFv): intravirion molecular therapies.
BouHamdan M; Kulkosky J; Duan LX; Pomerantz RJ
J Hum Virol; 2000; 3(1):6-15. PubMed ID: 10774802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
